Prevalence of pre-diabetes in young Mexican adults in primary health care

Family Practice

Volumn 32, Issue 2, 2015, Pages 159-164

  Ureña Bogarín, Enrique L ^a   Martínez Ramírez, Héctor R ^a   Torres Sánchez, José R ^a   Hernández Herrera, Aurora ^a   Cortés Sanabria, Laura ^a   Cueto Manzano, Alfonso M ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Mexican; Pre diabetes; Prevalence; Primary health care; Young adults

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MEXICAN; OBESITY; PREVALENCE; PRIMARY HEALTH CARE; RISK FACTOR; TOBACCO CONSUMPTION; WAIST CIRCUMFERENCE; YOUNG ADULT; ADOLESCENT; AGE; DIABETES MELLITUS; DRINKING BEHAVIOR; MEXICO; PREDIABETIC STATE; SMOKING; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; AGE FACTORS; ALCOHOL DRINKING; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; HUMANS; HYPERTENSION; MEXICO; OBESITY; PREDIABETIC STATE; PREVALENCE; PRIMARY HEALTH CARE; RISK FACTORS; SMOKING; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84926630199     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmu047     Document Type: Article

References (32)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014; 37 (suppl 1): 81-90.
2. Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet 2012; 379: 2279-90.
3. Cowie CC, Rust KF, Byrd-Holt DD et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care2006; 29: 1263-8.
4. Kim SM, Lee JS, Lee J et al. Prevalence of diabetes and impaired fasting glucose in Korea: Korean National Health and Nutrition Survey 2001. Diabetes Care 2006; 29: 226-31.
5. Esteghamati A, Gouya MM, Abbasi M et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care 2008; 31: 96-8.
6. Raghupathy P, Antonisamy B, Fall CH et al. High prevalence of glucose intolerance even among young adults in south India. Diabetes Res Clin Pract 2007; 77: 269-79.
7. Aekplakorn W, Abbott-Klafter J, Premgamone A et al. Prevalence and management of diabetes and associated risk factors by regions of Thailand: Third National Health Examination Survey 2004. Diabetes Care 2007; 30: 2007-12.
8. Eikenberg JD, Davy BM. Prediabetes: a prevalent and treatable, but often unrecognized, clinical condition. J Acad Nutr Diet 2013; 113:213-8.
9. Cueto-Manzano AM, Quintana-Piña E, Correa-Rotter R. Long-term CAPD survival and analysis of mortality risk factors: 12-year experience of a single Mexican center. Perit Dial Int 2001; 21: 148-53.
10. Shamah-Levy T, Cuevas-Nasu L, Méndez-Gómez-Humarán I, Jimenez-Aguilar A, Mendoza-Ramirez AJ, Villalpando S. [Obesity in Mexican school age children is associated with out-of-home food consumption:in the journey from home to school]. Arch Latinoam Nutr 2011; 61:288-95.
11. Jáuregui A, Villalpando S, Rangel-Baltazar E, Castro-Hernández J, Lara-Zamudio Y, Méndez-Gómez-Humarán I. The physical activity level of Mexican children decreases upon entry to elementary school. Salud Publica Mex 2011; 53: 228-36.
12. Gutiérrez JP, Rivera-Dommarco J, Shamah-Levy T et al. Encuesta Nacional de Salud y Nutrición 2012. Resultados Nacionales. Cuernavaca, México: Instituto Nacional de Salud Pública (MX), 2012.
13. Instituto Nacional de Estadística y Geografía: Causas de defunción. Defunciones Generales Totales Por Principales Causas de Mortalidad, 2011. http://www3.inegi.org.mx/sistemas/sisept/Default. aspx?t=mdemo107&s=est&c=23587 (accessed on 12 December 2013).
14. Guerrero-Romero F, Rodríguez-Morán M, Pérez-Fuentes R et al.Prediabetes and its relationship with obesity in Mexican adults: the Mexican Diabetes Prevention (MexDiab) Study. Metab Syndr Relat Disord 2008; 6: 15-23.
15. Instituto Nacional de Estadística y Geografía: Derechohabiencia y uso de servicios de salud. Población Protegida por los Servicios de salud, 2000 a 2011. http://www3.inegi.org.mx/sistemas/temas/default. aspx?s=est&c=21702 (accessed on 12 December 2013).
16. Cowie CC, Rust KF, Ford ES et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009; 32: 287-94.
17. Reynales-Shigematsu LM, Guerrero-López CM, Lazcano Ponce E et al. Instituto Nacional de Psiquiatria Ramón de la Fuente Muñiz; Instituto Nacional de Salud Pública; Secretraria de Salud. Encuesta Nacional de Adicciones 2011: Reporte de Tabaco. http://www.conadic.salud.gob. mx/pdfs/ENA_2011_TABACO.pdf (accessed on 12 December 2013).
18. Medina-Mora ME, Villatoro-Velázquez JA, Fleiz-Bautista C et al. Encuesta Nacional de Adicciones 2011: Reporte de Alcohol. http://www.conadic.salud.gob.mx/pdfs/ENA_2011_ALCOHOL.pdf (accessed on 12 December 2013).
19. Langenberg C, Sharp SJ, Franks PW et al. Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort study. PLoS Med2014; 11: e1001647.
20. Hivert MF, Jablonski KA, Perreault L et al. Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program. Diabetes 2011; 60: 1340-8.
21. Ferrannini E, Nannipieri M, Williams K, Gonzales C, Haffner SM, Stern MP. Mode of onset of type 2 diabetes from normal or impaired glucose tolerance. Diabetes 2004; 53: 160-5.
22. Norris SL, Kansagara D, Bougatsos C, Fu R. Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2008; 148: 855-68.
23. Tuomilehto J, Lindström J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-50.
24. Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
25. Knowler WC, Fowler SE, Hamman RF et al. Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009; 374: 1677-86.
26. Gillies CL, Abrams KR, Lambert PC et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. Br Med J 2007; 334: 299.
27. Coulter A, Ellins J. Effectiveness of strategies for informing, educating, and involving patients. Br Med J 2007; 335: 24-7.
28. Coleman MT, Newton KS. Supporting self-management in patients with chronic illness. Am Fam Physician 2005; 72: 1503-10.
29. Prochaska JO. Multiple Health Behavior Research represents the future of preventive medicine. Prev Med 2008; 46: 281-5.
30. Waugh N, Scotland G, McNamee P et al. Screening for type 2 diabetes:literature review and economic modelling. Health Technol Assess2007; 11: 1-125.
31. Raikou M, McGuire A. The economics of screening and treatment in type 2 diabetes mellitus. Pharmacoeconomics 2003; 21: 543-64.
32. Aguilar-Salinas CA, Velazquez Monroy O, Gómez-Pérez FJ et al.Characteristics of patients with type 2 diabetes in México: results from a large population-based nationwide survey. Diabetes Care 2003; 26: 2021-6.